Lipitor (Atorvastatin Calcium) Products Liability Litigation
MDL No. 2502


This multidistrict litigation currently consists of over two thousand cases pending before this Court, and additional cases are expected to be filed or transferred to this Court in the coming months. These cases all involve allegations concerning the medication Lipitor (Atorvastatin Calcium). Lipitor is commonly prescribed to aid in lowering cholesterol and triglycerides. The plaintiffs allege that Lipitor caused them to develop type 2 diabetes and related injuries. Pfizer denies these claims.

The Judicial Panel on Multidistrict Litigation determined that the Lipitor cases filed involved common questions of fact and that centralization of the Lipitor cases was appropriate. Weighing a number of factors, the Judicial Panel selected the District of South Carolina as the forum for this litigation. These cases have been assigned to the Honorable Richard M. Gergel for coordinated discovery and pretrial matters.